Glucose Monitoring

Latest News

April 9th 2020

What We're Reading: Centivo Launches New Plan; Dead Bacteria Provide IBS Relief; Hospitals Using CGM in Patients With COVID-19

By AJMC Staff

April 2nd 2020

Women With GDM, Vitamin D Deficiency May Have Higher Risk of Postpartum Glucose Intolerance

By Gianna Melillo

February 25th 2020

Abbott, DexCom Partner With Insulet to Improve Diabetes Management Technology

By Gianna Melillo

August 28th 2019

Keeping Glucose in Range, With the Right Tools and Treatment for Management

By Mary Caffrey

June 30th 2019

Managing Costs in Diabetes Means Intervening Early to Avoid Complications Later, Experts Say

By Mary Caffrey

Video Interviews

July 14th 2017

This Week in Managed Care: July 14, 2017

June 21st 2017

Raymie McFarland Discusses Findings From Glytec's Basal-Bolus Insulin Study

June 13th 2017

Dr Eda Cengiz Explains Artificial Pancreas Systems' Implications for Patients and Clinicians

June 11th 2017

Dr William Polonsky on the Promising Potential of Continuous Glucose Monitoring

June 10th 2017

Dr Robert Gabbay Highlights 3 Exciting Areas of Developing Diabetes Technology

May 15th 2017

Impact of Cardiovascular Evidence on Diabetes

May 15th 2017

Understanding Cardiovascular Benefit With the LEADER Trial

May 15th 2017

GLP-1 Receptor Agonists: Initial Cardiovascular Evidence

May 15th 2017

Cardiovascular Benefit With SGLT2 Inhibition

May 15th 2017

Diabetes: Shifting the Mindset for Cardiovascular Benefits

Podcasts

August 26th 2017

Podcast: This Week in Managed Care - When to Start Mammography, and Other Health News

July 15th 2017

Podcast: This Week in Managed Care - Insurers Avoid HealthCare.gov, and Other Health News

More News

Using Real-World Evidence to Understand Disparities, Clinical Inertia

June 18th 2019

Using Real-World Evidence to Understand Disparities, Clinical Inertia

Merck's Center for Observational and Real-World Evidence has spent several years gathering evidence on clinical inertia and is now working on solutions to overcome it at the point of care.

ADA Issues Time-in-Range Targets for CGM Use

June 14th 2019

ADA Issues Time-in-Range Targets for CGM Use

The consensus report was presented at the 79th Scientific Sessions of the American Diabetes Association in San Francisco, California.

Real-World Data Show Patients With T2D Reducing A1C With FreeStyle Libre

June 10th 2019

Real-World Data Show Patients With T2D Reducing A1C With FreeStyle Libre

Patients with type 2 diabetes (T2D) who had been using insulin an average of 8 years and had mean glycated hemoglobin (A1C) levels of 8.9% were able to bring their levels down 0.9% after 3 months, according to chart review data from 3 European countries.

Horizon and Aetion Partner to Optimize Treatment Pathways and Cut Healthcare Costs

June 7th 2019

Horizon and Aetion Partner to Optimize Treatment Pathways and Cut Healthcare Costs

Wallace Stephens

Aetion announced the company partnered with Horizon Healthcare Services to identify high-risk patients and optimal treatment pathways as a means to achieve better health outcomes and cut healthcare costs.

Data Show New US Diabetes Cases Are Taking a Dip

June 3rd 2019

Data Show New US Diabetes Cases Are Taking a Dip

The authors, from the CDC, say that while the decline in diabetes incidence occurred alongside public health efforts, it's too soon to assume a causal relationship.

Use of CGM Can Help Diagnose Impaired Hypoglycemia Awareness

May 31st 2019

Use of CGM Can Help Diagnose Impaired Hypoglycemia Awareness

Lack of awareness of hypoglycemia symptoms can be dangerous, because the person with diabetes can experience a dangerous drop in blood sugar; chronic low blood glucose can result in complications.

Medtronic Says MiniMed 670G Glucose Management System Increased Time in Range for People With Diabetes

May 30th 2019

Medtronic Says MiniMed 670G Glucose Management System Increased Time in Range for People With Diabetes

Wallace Stephens

Medtronic says real-world data show its MiniMed 670G glucose management system increased time in range for people with diabetes.

LifeScan Finds Partner to Move Into CGM Market

May 23rd 2019

LifeScan Finds Partner to Move Into CGM Market

A well-known brand of blood glucose meters, lancets, and test strips has tapped Sanvita Medical to develop sensors that integrate with its OneTouch Reveal diabetes management app.

FDA Issues Warning on Do-It-Yourself Artificial Pancreas

May 19th 2019

FDA Issues Warning on Do-It-Yourself Artificial Pancreas

Some people living with type 1 diabetes are unhappy with commercial technology currently avaiable, while others see their choices limited by payer coverage decisions.

First-in-Human Study of Dual Inhibitor Licogliflozin Showed Significant Weight Loss in Obese Patients

May 18th 2019

First-in-Human Study of Dual Inhibitor Licogliflozin Showed Significant Weight Loss in Obese Patients

Dual inhibitors target both the SGLT1 and SGLT2 proteins in the digestive and renal systems to prevent reuptake of excess glucose.

Sales of Sweetened Drinks Fell 38% After Philadelphia Beverage Tax

May 14th 2019

Sales of Sweetened Drinks Fell 38% After Philadelphia Beverage Tax

Wallace Stephens

Findings from a new study have shown that sales of sweetened drinks fell by 38% after Philadelphia implemented a tax on sugary beverages.

UCLA Freshman Wins Microsoft Prize With Glucose Test That Snaps Eye Photo

May 10th 2019

UCLA Freshman Wins Microsoft Prize With Glucose Test That Snaps Eye Photo

Bryan Chiang's concept lets a user take a photo of the eye using a special adapter on the smartphone; the image is then analyzed to predict blood glucose levels.

One-Third of Type 1 Diabetes Cases Misdiagnosed in Those Over Age 30

May 4th 2019

One-Third of Type 1 Diabetes Cases Misdiagnosed in Those Over Age 30

Older patients who are improperly diagnosed may not gain access to insulin and delivery and monitoring tools, such as pumps or continuous glucose monitoring.

April 29th 2019

Liraglutide Lowers A1C in Youth With Type 2 Diabetes, Phase 3 Study Finds

The results may lead to the first new option in years for youth with type 2 diabetes, besides metformin and insulin.

Few At-Risk Adults Are Being Referred to Diabetes Prevention Programs, Study Finds

April 27th 2019

Few At-Risk Adults Are Being Referred to Diabetes Prevention Programs, Study Finds

The CDC created the National Diabetes Prevention Program following a study of a lifestyle intervention; new results show that more than a third of adults who are referred to a program take part, but only a fraction are referred.

CGM Linked to Low A1C Among Blog Readers With Type 1 Diabetes

April 24th 2019

CGM Linked to Low A1C Among Blog Readers With Type 1 Diabetes

The study by researchers at Penn State College of Medicine found those with type 1 diabetes who read blogs had lower glycated hemoglobin (A1C) levels, and the combination of reading blogs and using continuous glucose monitoring produced the best glycemic control.

CREDENCE: Canagliflozin Cuts Risk of Renal Failure, Death 30% in Patients With Type 2 Diabetes, CKD

April 15th 2019

CREDENCE: Canagliflozin Cuts Risk of Renal Failure, Death 30% in Patients With Type 2 Diabetes, CKD

Results of the landmark study, the first in a series of renal outcomes studies for SGLT2 inhibitors, will be of great interest to policy makers given the cost of dialysis to Medicare.

As Comorbidities Pile Up, True Diabetes Cost Measured by More Than Insulin, Panel Says

April 14th 2019

As Comorbidities Pile Up, True Diabetes Cost Measured by More Than Insulin, Panel Says

Allison Inserro

For endocrinologists, a cardiologist, a diabetes educator, and a room full of fellow health workers, the cost of doing nothing—not just to treat diabetes, but also to prevent it— is what feeds into the exorbitant cost of the disease, according to presentations and a panel at the inaugural meeting of the Institute for Value Based Medicine (IVBM) in Diabetes, an initiative of The American Journal of Managed Care®.

March 31st 2019

Continuous Glucose Monitoring: An Emerging Standard of Care

John B. Welsh, MD, PhD Roy Thomas, PharmD

The potential value of continuous monitoring of blood glucose and the enzyme-based electrode that underlies continuous glucose monitoring (CGM) in the subcutaneous tissue were described in the 1960s. In 1999, the FDA approved the first “professional” CGM system, which stored data over 3 days for later retrieval and analysis. However, many patients (even volunteers in CGM-based clinical trials) found early-generation systems uncomfortable and difficult to wear. By contrast, current systems are more accurate, provide customizable alerts and alarms, are easier to use and less likely to cause skin irritation, resist interference from acetaminophen, allow for real-time data to be shared and remotely monitored, and are stable enough so as not to require periodic calibrations with SMBG values.

March 31st 2019

A New Era: Increasing Continuous Glucose Monitoring Use in Type 2 Diabetes

Tejaswi Kompala, MD Aaron Neinstein, MD, FAMIA

Continuous glucose monitors (CGMs) are increasingly accessible and effective for patients with type 2 diabetes (T2D), and even those with prediabetes, as a means for real-time biofeedback and behavior change.

March 31st 2019

FreeStyle Libre CGM Sees Rising Use With Pharmacy Chain Distribution

When the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring (CGM) system in September 2017, diabetes advocates hailed the move as long overdue and one that might lead to greater penetration of glucose monitoring technology for those with type 2 diabetes.

March 30th 2019

Bariatric Surgery Study Shows Potential of Using CGM in Clinical Research

In 2017, as advocates and researchers discussed the potential for continuous glucose monitoring (CGM) to become a tool in clinical trials, most of the discussion involved testing in new therapies. The discussion culminated in an international consensus on CGM, published in December 2017, that included standards for assessing hypoglycemia in clinical trials.

March 29th 2019

Three Years After Advocates Report Flaws, Medicare Diabetes Test Strip Bidding Program Nears Collapse

Samantha DiGrande Mary Caffrey

Three years after results from a study in Diabetes Care revealed how flaws in CMS’ Competitive Bidding Program endangered Medicare patients who rely on supplies to test their blood glucose, the federal government has allowed contracts to expire for the dwindling number of suppliers, raising fears that the program for seniors with diabetes has reached the point of collapse.

March 18th 2019

Relationship Between Heart Failure and Diabetes Seen Throughout ACC Sessions

More than a decade after an FDA mandate for cardiovascular outcomes trials, cardiologists say insights gained on how 2 new drug classes affect heart failure in diabetes should be used to prevent complications. Several sessions at the 68th Scientific Session of the American College of Cardiology addressed this topic.

SGLT2 Inhibitors Work by Inducing Fasting State, Joslin Center Scientist Says

March 8th 2019

SGLT2 Inhibitors Work by Inducing Fasting State, Joslin Center Scientist Says

Allison Inserro

The study illuminates how the weight loss, reduction in fatty liver disease, and a decreased risk for cardiovascular disease happens in patients taking SGLT2 inhibitors.

FDA Clears Phone App for d-Nav Insulin Guidance Service

February 21st 2019

FDA Clears Phone App for d-Nav Insulin Guidance Service

Digital tools for managing diabetes and insulin have proliferated in recent years.

CGM Shows When Bariatric Surgery Patients Need Diabetes Therapy Adjustments

February 15th 2019

CGM Shows When Bariatric Surgery Patients Need Diabetes Therapy Adjustments

The study used the Freestyle Libre to track blood glucose levels in patients with and without type 2 diabetes (T2D) who had different surgical procedures; the CGM showed a drop in glucose on the third day after surgery among patients with T2D who had gastric bypass.

New Look at VA Diabetes Trial Links Severe Hypoglycemia, Cardiovascular Events

January 7th 2019

New Look at VA Diabetes Trial Links Severe Hypoglycemia, Cardiovascular Events

The initial trial made news because the results were at odds with ACCORD. This new analysis highlights the need for personalized diabetes care, especially among older adults.

FDA to Review SGLT1/2 Inhibitor Sotagliflozin as Possible Treatment for Type 1 Diabetes

May 24th 2018

FDA to Review SGLT1/2 Inhibitor Sotagliflozin as Possible Treatment for Type 1 Diabetes

Clinical trial data has shown that the drug helped 28.6% of patients achieve glycated hemoglobin of 7.0% of less by week 24 without severe hypoglycemia or diabetic ketoacidosis and also helped participants lose weight.

Great Recession Had Negative Impact on Blood Pressure, Glucose, Study Finds

March 12th 2018

Great Recession Had Negative Impact on Blood Pressure, Glucose, Study Finds

Allison Inserro

The Great Recession was associated with increased blood pressure and glucose levels, especially among groups of older homeowners and individuals younger than 65 years still employed, according to new research published in Proceedings of the National Academy of Sciences. Medication use fell after the Great Recession, and the results provide strong evidence that economic crises can have measurable effects on public health.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions